Physician profile
Liya Beyderman
NPI 1699816017
$2,035.70
in general payments reported to CMS, 2019-2025
12 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2021: $169 · 2022: $340 · 2023: $639 · 2024: $122 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $899.18 | 2019-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $528.82 | 2021-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Greenwich Biosciences, INC. | $132.45 | 2021 | |
| Corium, LLC | $126.20 | 2022-2023 | Azstarys |
| Eisai INC. | $113.36 | 2019 | |
| Neos Therapeutics, LP | $54.45 | 2023-2025 | Cotempla Xr-Odt |
| Collegium Pharmaceutical, INC. | $45.39 | 2025 | Jornay Pm |
| Shire North American Group INC | $35.35 | 2019 | |
| Livanova USA, INC. | $34.15 | 2019 | |
| Vertical Pharmaceuticals, LLC | $28.62 | 2025 | Relexxii |
| Ucb, INC. | $26.19 | 2019 | |
| Bausch Health US, LLC | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liya Beyderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.